由MECOM进行的CEBPA镇压阻止了分化,从而驱动了侵袭性白血病
Travis J Fleming1,2,3,4, Mateusz Antoszewski1,2,3,4, Sander Lambo1,2,4
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
Blood
|September 24, 2025
概括
研究人员发现,MECOM基因通过阻断细胞分化来驱动具有攻击性的急性髓性白血病 (AML). 针对特定的调节元件可以扭转这种情况,促进AML细胞分化并减少瘤负担.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 急性髓性白血病 (AML) 往往有不良预后,特别是利用干细胞基因调节程序的高风险病例.
- 转录因子MECOM在AML中经常过度表达,导致侵袭性疾病,但其确切的作用机制尚不清楚.
研究的目的:
- 阐明MECOM通过哪些机制来促进积极的AML表型.
- 在MECOM驱动的致癌网络中确定新的治疗点.
主要方法:
- 工程化向蛋白质降解与功能性基因组读取相结合.
- 研究了MECOM在抑制原差异化基因调控程序中的作用.
- 分析了CEBPA下游的一个特定的MECOM-bound cis-regulatory元素.
主要成果:
- 通过抑制分化途径,MECOM被证明可以促进恶性干细胞样状态.
- 一个单一的cis-regulatory元素,CEBPA下游42kb,被确定为维持MECOM驱动型白血病的关键.
- 这种元素的有针对性的激活诱导了AML细胞分化,并在体内减少了白血病负担.
结论:
- 通过特定的监管要素,MECOM通过抑制差异化计划来推动积极的AML.
- 针对已识别的CEBPA相关监管要素,为AML提供了一个潜在的治疗策略.
- 这项研究表明了剖析癌症基因调节网络在癌症中的强大方法.
相关概念视频
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K


